Higher glucocorticoid secretion in the physiological range is associated with lower bone strength at the proximal radius in healthy children: Importance of protein intake adjustment

Journal of Bone and Mineral Research

Volumn 30, Issue 2, 2015, Pages 240-248

  Shi, Lijie ^a   Sánchez Guijo, Alberto ^b   Hartmann, Michaela F ^b   Schönau, Eckhard ^c   Esche, Jonas ^a   Wudy, Stefan A ^b   Remer, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

11 Hydroxysteroid dehydrogenase type 1; Bone; Bone modeling; Bone remodeling; Cortisol secretion; Cortisone; Glucocorticoids; Healthy children; PQCT

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CREATININE; GLUCOCORTICOID; NITROGEN; SODIUM; BIOLOGICAL MARKER; PROTEIN INTAKE;

ANTHROPOMETRY; ARTICLE; BONE CELL; BONE MINERAL; BONE STRENGTH; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GEOMETRY; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLITE; PERIOSTEUM; PROTEIN INTAKE; RADIUS; URINALYSIS; URINARY EXCRETION; ADOLESCENT; BONE DENSITY; DIET; DRUG EFFECTS; HEALTH; PHARMACOLOGY; PHYSIOLOGY; REFERENCE VALUE; SECRETION (PROCESS); URINE;

ADOLESCENT; BIOMARKERS; BONE DENSITY; CHILD; DIET; DIETARY PROTEINS; FEMALE; GLUCOCORTICOIDS; HEALTH; HUMANS; MALE; RADIUS; REFERENCE VALUES;

EID: 84921722981     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2347     Document Type: Article

References (60)

1. Compston J. Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol. 2010;6(2):82-8.
2. Hardy R, Cooper MS. Adrenal gland and bone. Arch Biochem Biophys. 2010;503(1):137-45.
3. Altindag O, Altindag A, Asoglu M, Gunes M, Soran N, Deveci Z. Relation of cortisol levels and bone mineral density among premenopausal women with major depression. Int J Clin Pract. 2007;61(3):416-20.
4. Biller BM, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab. 1989;68(3):548-54.
5. Eskandari F, Martinez PE, Torvik S, et al. Low bone mass in premenopausal women with depression. Arch Intern Med. 2007;167(21):2329-36.
6. Kahl KG, Rudolf S, Stoeckelhuber BM, et al. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. Am J Psychiatry. 2005;162(1):168-74.
7. Legroux-Gerot I, Vignau J, D'Herbomez M, et al. Evaluation of bone loss and its mechanisms in anorexia nervosa. Calcif Tissue Int. 2007;81(3):174-82.
8. Naessen S, Carlstrom K, Glant R, Jacobsson H, Hirschberg AL. Bone mineral density in bulimic women - influence of endocrine factors and previous anorexia. Eur J Endocrinol. 2006;155(2):245-51.
9. Petronijevic M, Petronijevic N, Ivkovic M, et al. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression. Bone. 2008;42(3):582-90.
10. Yazici AE, Bagis S, Tot S, Sahin G, Yazici K, Erdogan C. Bone mineral density in premenopausal women with major depression. Joint Bone Spine. 2005;72(6):540-3.
11. Bedford JL, Barr SI. The relationship between 24-h urinary cortisol and bone in healthy young women. Int J Behav Med. 2010;17(3):207-15.
12. Cetin A, Gokce-Kutsal Y, Celiker R. Predictors of bone mineral density in healthy males. Rheumatol Int. 2001;21(3):85-8.
13. Reynolds RM, Dennison EM, Walker BR, et al. Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. Calcif Tissue Int. 2005;77(3):134-8.
14. Greendale GA, Unger JB, Rowe JW, Seeman TE. The relation between cortisol excretion and fractures in healthy older people: results from the MacArthur studies-Mac. J Am Geriatr Soc. 1999;47(7):799-803.
15. Dennison E, Hindmarsh P, Fall C, et al. Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab. 1999;84(9):3058-63.
16. Remer T, Boye KR, Hartmann M, et al. Adrenarche and bone modeling and remodeling at the proximal radius: weak androgens make stronger cortical bone in healthy children. J Bone Miner Res. 2003;18(8):1539-46.
17. Alexy U, Remer T, Manz F, Neu CM, Schoenau E. Long-term protein intake and dietary potential renal acid load are associated with bone modeling and remodeling at the proximal radius in healthy children. Am J Clin Nutr. 2005;82(5):1107-14.
18. Schurch MA, Rizzoli R, Slosman D, Vadas L, Vergnaud P, Bonjour JP. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;128(10):801-9.
19. Slag MF, Ahmad M, Gannon MC, Nuttall FQ. Meal stimulation of cortisol secretion: a protein induced effect. Metabolism. 1981;30(11):1104-8.
20. Gibson EL, Checkley S, Papadopoulos A, Poon L, Daley S, Wardle J. Increased salivary cortisol reliably induced by a protein-rich midday meal. Psychosom Med. 1999;61(2):214-24.
21. Remer T, Maser-Gluth C. Simultaneous measurements of urinary free cortisol and cortisone for the assessment of functional glucocorticoid activity. Clin Chem. 2007;53(10):1870-1.
22. Remer T, Maser-Gluth C, Wudy SA. Glucocorticoid measurements in health and disease - metabolic implications and the potential of 24-h urine analyses. Mini Rev Med Chem. 2008;8(2):153-70.
23. Cooper MS, Syddall HE, Fall CH, et al. Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study. Clin Endocrinol (Oxf). 2005;62(6):692-7.
24. Stewart PM. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur J Endocrinol. 2003;149(3):163-8.
25. Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M, Stewart PM. Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. Bone. 2000;27(3):375-81.
26. Cooper MS. 11beta-Hydroxysteroid dehydrogenase: a regulator of glucocorticoid response in osteoporosis. J Endocrinol Invest. 2008;31(7 Suppl):16-21.
27. Neu CM, Rauch F, Manz F, Schoenau E. Modeling of cross-sectional bone size, mass and geometry at the proximal radius: a study of normal bone development using peripheral quantitative computed tomography. Osteoporos Int. 2001;12(7):538-47.
28. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight are known. Arch Intern Med. 1916;17:863-71.
29. Slaughter MH, Lohman TG, Boileau RA, et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol. 1988;60(5):709-23.
30. Remer T, Boye KR, Hartmann MF, Wudy SA. Urinary markers of adrenarche: reference values in healthy subjects, aged3-1. years. J Clin Endocrinol Metab. 2005;90(4):2015-21.
31. Wudy SA, Hartmann MF, Remer T. Sexual dimorphism in cortisol secretion starts after age 10 in healthy children: urinary cortisol metabolite excretion rates during growth. Am J Physiol Endocrinol Metab. 2007;293(4):E970-6.
32. Sanchez-Guijo A, Hartmann MF, Shi L, Remer T, Wudy SA. Determination of free cortisol and free cortisone in human urine by on-line turbulent flow chromatography coupled to fused-core chromatography-tandem mass spectrometry (TFC-HPLC-MS/MS). Anal Bioanal Chem. 2014;406(3):793-801.
33. Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf). 1996;45(5):605-11.
34. Best R, Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf). 1997;47(2):231-6.
35. Shi L, Wudy SA, Maser-Gluth C, Hartmann MF, Remer T. Urine volume dependency of specific dehydroepiandrosterone (DHEA) and cortisol metabolites in healthy children. Steroids. 2011;76(1-2):140-4.
36. Remer T, Manz F, Alexy U, Schoenau E, Wudy SA, Shi L. Long-term high urinary potential renal acid load and low nitrogen excretion predict reduced diaphyseal bone mass and bone size in children. J Clin Endocrinol Metab. 2011;96(9):2861-8.
37. Dimitriou T, Maser-Gluth C, Remer T. Adrenocortical activity in healthy children is associated with fat mass. Am J Clin Nutr. 2003;77(3):731-6.
38. Beck TJ, Petit MA, Wu G, LeBoff MS, Cauley JA, Chen Z. Does obesity really make the femur stronger? BMD, geometry, and fracture incidence in the women's health initiative-observational study. J Bone Miner Res. 2009;24(8):1369-79.
39. Toth M, Grossman A. Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome. Clin Endocrinol (Oxf). 2013;79(1):1-11.
40. Shi L, Libuda L, Schonau E, Frassetto L, Remer T. Long term higher urinary calcium excretion within the normal physiologic range predicts impaired bone status of the proximal radius in healthy children with higher potential renal acid load. Bone. 2012;50(5):1026-31.
41. Hermus AR, Smals AG, Swinkels LM, et al. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab. 1995;80(10):2859-65.
42. Delany AM, Gabbitas BY, Canalis E. Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms. J Cell Biochem. 1995;57(3):488-94.
43. Delany AM, Canalis E. Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells. Endocrinology. 1995;136(11):4776-81.
44. Rydziel S, Canalis E. Cortisol represses insulin-like growth factor II receptor transcription in skeletal cell cultures. Endocrinology. 1995;136(10):4254-60.
45. Cooper MS. Glucocorticoids in bone and joint disease: the good, the bad and the uncertain. Clin Med. 2012;12(3):261-5.
46. Acar B, Uslu T, Topuz A, et al. Relation between bone mineral content and clinical, hormonal and biochemical parameters in postmenopausal women. Arch Gynecol Obstet. 1998;261(3):121-8.
47. Raff H, Raff JL, Duthie EH, et al. Elevated salivary cortisol in the evening in healthy elderly men and women: correlation with bone mineral density. J Gerontol A Biol Sci Med Sci. 1999;54(9):M479-83.
48. Remer T, Maser-Gluth C, Boye KR, Hartmann MF, Heinze E, Wudy SA. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children. Steroids. 2006;71(7):591-8.
49. Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab. 1997;82(1):151-5.
50. Bland R, Worker CA, Noble BS, et al. Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. J Endocrinol. 1999;161(3):455-64.
51. Hardy RS, Filer A, Cooper MS, et al. Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation. Arthritis Res Ther. 2006;8(4):R108.
52. Cooper MS, Blumsohn A, Goddard PE, et al. 11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone. J Clin Endocrinol Metab. 2003;88(8):3874-7.
53. Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res. 2002;17(6):979-86.
54. Ramli ES, Suhaimi F, Asri SF, Ahmad F, Soelaiman IN. Glycyrrhizic acid (GCA) as 11beta-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis. J Bone Miner Metab. 2013;31(3):262-73.
55. Eijken M, Koedam M, van Driel M, Buurman CJ, Pols HA, van Leeuwen JP. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol. 2006;248(1-2):87-93.
56. Park JS, Bae SJ, Choi SW, et al. A novel 11beta-HSD1 inhibitor improves diabesity and osteoblast differentiation. J Mol Endocrinol. 2014;52(2):191-202.
57. Wu L, Qi H, Zhong Y, et al. 11beta-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction. Endocr J. 2013;60(9):1047-58.
58. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 1981;53(1):58-68.
59. Schoenau E, Neu CM, Rauch F, Manz F. Gender-specific pubertal changes in volumetric cortical bone mineral density at the proximal radius. Bone. 2002;31(1):110-3.
60. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al. [Percentiles of body mass index in children and adolescents evaluated from different regional German studies]. Monatsschr Kinderheilkd. 2001;149(8):807-18. German.